CAREERS

Facebook-f Linkedin
ORDER NOW

Olivia Correa

September FDA Decisions: Key Updates in Acromegaly and Cancer Treatments

Industry /

Last month brought pivotal FDA decisions that could shape the future of care in endocrinology and oncology. Two highly anticipated reviews—the approval of Crinetics Pharmaceuticals’ new oral treatment for acromegaly and the FDA’s decision on Merck’s subcutaneous formulation of Keytruda—captured the industry’s attention. Crinetics Pharmaceuticals: Oral Acromegaly Treatment On September 25, the FDA announced its […]

September FDA Decisions: Key Updates in Acromegaly and Cancer Treatments Read More »

Unit Dose Repackaging: How We Deliver Safe, Reliable Solutions

Unit Dose /

At Atlantic Biologicals, our mission has always been clear: provide healthcare providers with the highest quality pharmaceutical products while ensuring safety, compliance, and efficiency at every step. One of the ways we uphold this standard is through unit dose repackaging. Why Repackaging Matters Repackaging plays a critical role in today’s healthcare environment. By transforming medications

Unit Dose Repackaging: How We Deliver Safe, Reliable Solutions Read More »

pharmaceutical industry

The Impact of Mergers and Acquisitions on the Pharmaceutical Industry

Industry /

One of the most significant trends shaping the market today is the rise of mergers and acquisitions (M&A). Large companies in the pharmaceutical industry have been acquiring smaller biotech firms. In result, expanding their pipelines and investing in groundbreaking therapies. How Mergers and Acquisitions Drive Innovation Companies like Novartis are demonstrating a strong interest in

The Impact of Mergers and Acquisitions on the Pharmaceutical Industry Read More »

hazardous medications

Atlantic Biologicals: Providing Safe and Compliant Hazardous Medication

Unit Dose /

Hospitals and pharmacies must navigate complex regulations while ensuring patient safety. One critical aspect of pharmaceutical management is the handling of potentially hazardous medications. At Atlantic Biologicals, we understand the importance of providing healthcare facilities with safe and compliant solutions for these high-risk medications. Why These Medications Require Specialized Handling Hazardous medications, as classified by

Atlantic Biologicals: Providing Safe and Compliant Hazardous Medication Read More »

AI and Data Analytics

AI and Data Analytics: Transforming Pharmaceutical Innovation

Industry /

The pharmaceutical industry is undergoing a transformative shift, with artificial intelligence (AI) and big data analytics playing a crucial role in accelerating medication discovery and development. Companies are leveraging these cutting-edge technologies to streamline research, improve efficiency, and enhance patient outcomes. As the demand for faster and more cost-effective medication development grows, AI-driven approaches are

AI and Data Analytics: Transforming Pharmaceutical Innovation Read More »

Non-Opioid Pain Medication

FDA Approves Vertex Pharmaceuticals’ Non-Opioid Pain Medication, Marking a Shift in Pain Management

General Pharmaceuticals /

The FDA recently approved Vertex Pharmaceuticals’ groundbreaking non-opioid pain medication, Journavx. This approval represents a major milestone in pain management. It offers patients an alternative to opioid-based treatments while addressing concerns about addiction and dependency. The decision comes at a critical time when the healthcare industry is actively seeking safer and more effective pain relief

FDA Approves Vertex Pharmaceuticals’ Non-Opioid Pain Medication, Marking a Shift in Pain Management Read More »

Pharmapack 2025

Pharmapack 2025: A Hub for Innovation in Pharmaceutical Packaging and Delivery

Industry /

Pharmapack 2025, one of the most anticipated events in the pharmaceutical and healthcare industries, is set to take place in Paris, France. Scheduled for this month, this global gathering will bring together key players from pharmaceutical packaging, medication delivery, medical devices, and machinery sectors. The event promises to spotlight cutting-edge innovations and foster meaningful collaborations

Pharmapack 2025: A Hub for Innovation in Pharmaceutical Packaging and Delivery Read More »

Big Pharma

What the NFL Draft Can Teach Investors About Big Pharma

Industry /

When you think about the NFL Draft, images of scouts, strategy, and high-stakes decisions come to mind. Big Pharma, on the other hand, conjures up thoughts of clinical trials, research breakthroughs, and regulatory hurdles. At first glance, these two industries might seem worlds apart. However, for investors, the parallels between the NFL Draft and Big

What the NFL Draft Can Teach Investors About Big Pharma Read More »

Medicare PDPs to Have Annual Out-of-Pocket Cap Starting in 2025

General Pharmaceuticals /

Starting in January 2025, significant changes will be coming to Medicare prescription drug plans (PDPs) that aim to make prescription medications more affordable for millions of Americans. As part of the Inflation Reduction Act, the federal government is implementing an annual out-of-pocket cap of $2,000 on covered prescription medications. This move is designed to ease

Medicare PDPs to Have Annual Out-of-Pocket Cap Starting in 2025 Read More »

Public Health Risk

CDC Warns of Potential Public Health Risk from Online Pharmacies and Counterfeit Medications

Uncategorized /

The Centers for Disease Control and Prevention (CDC) has issued a warning about the public health risk associated with online pharmacies. The warning specifically highlights the dangers posed by pharmacies that sell counterfeit or substandard medications. As more people turn to the internet to purchase prescriptions, the risk of unknowingly obtaining harmful medications increases. Many

CDC Warns of Potential Public Health Risk from Online Pharmacies and Counterfeit Medications Read More »